Form 8-K - Current report:
SEC Accession No. 0000200406-21-000067
Filing Date
2021-10-19
Accepted
2021-10-19 08:01:28
Documents
19
Period of Report
2021-10-19
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K jnj-20211019.htm   iXBRL 8-K 54665
2 EX-99.1 a2021q3exhibit991.htm EX-99.1 62276
3 EX-99.2 a2021q3exhibit992.htm EX-99.2 1193427
4 EX-99.3 a2021q3exhibit993.htm EX-99.3 15429
9 a3q21overallfinancialresul.jpg GRAPHIC 12975
10 a3q21regionalfinancialresu.jpg GRAPHIC 7696
11 a3q21salesbysegment.jpg GRAPHIC 8754
  Complete submission text file 0000200406-21-000067.txt   1647400

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jnj-20211019.xsd EX-101.SCH 3542
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jnj-20211019_def.xml EX-101.DEF 17377
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jnj-20211019_lab.xml EX-101.LAB 35650
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jnj-20211019_pre.xml EX-101.PRE 18240
12 EXTRACTED XBRL INSTANCE DOCUMENT jnj-20211019_htm.xml XML 21511
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Filer) CIK: 0000200406 (see all company filings)

EIN.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 0102
Type: 8-K | Act: 34 | File No.: 001-03215 | Film No.: 211329659
SIC: 2834 Pharmaceutical Preparations